Patents by Inventor Szu-Ting LIU

Szu-Ting LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230023218
    Abstract: The embodiments of the present disclosure provide a cell culture composition and a use thereof, and the cell culture composition includes a culture medium and mitochondria. The cell culture composition including mitochondria can promote cell growth and improve the function of the damaged or aged stem cells, thereby improving overall cell growth.
    Type: Application
    Filed: September 19, 2022
    Publication date: January 26, 2023
    Applicant: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung CHENG, Chih-Kai HSU, Hui-Ching TSENG, Shun-Chieh YANG, Chi-Tang TU, Szu-Ting LIU, Li-Hsin YAO
  • Publication number: 20230003625
    Abstract: An agent for cryopreservation includes trehalose, HEPES and serum albumin. The agent for cryopreservation does not include potassium chloride, sodium chloride, ethylene glycol, ethylene glycol tetraacetic acid and ethylenediaminetetraacetic acid.
    Type: Application
    Filed: August 26, 2022
    Publication date: January 5, 2023
    Applicant: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Chi-Tang TU, Szu-Ting LIU, Li-Hsin YAO, Han-Chung CHENG
  • Patent number: 10342834
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: July 9, 2019
    Assignee: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Szu-Ting Liu
  • Publication number: 20190142889
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Application
    Filed: January 8, 2019
    Publication date: May 16, 2019
    Applicant: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO.,LTD.
    Inventors: Han-Chung CHENG, Chi-Tang TU, Szu-Ting LIU
  • Patent number: 10213467
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: February 26, 2019
    Assignee: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Szu-Ting Liu
  • Publication number: 20170151297
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Applicant: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO.,LTD.
    Inventors: Han-Chung CHENG, Chi-Tang TU, Szu-Ting LIU